"Today's marketing authorization provides certain patients with access to a new hearing aid that provides them with direct control over the fit and functionality of the device," said Malvina Eydelman, MD, director of the FDA's Division of Ophthalmic, and Ear, Nose and Throat Devices.
The approval of the test was based on a clinical study (N=96) which compared the iHEARtest with the WHO method for determining hearing impairment.
For the migraine and non-migraine cohorts, the incidence rates of cochlear disorders were 81.4 and 29.4 per 1 million person-years, respectively.
In 33% of children in the cisplatin-sodium thiosulfate group and 63% in the cisplatin-alone group, hearing loss of grade 1 or higher occurred, which indicated a 48% lower incidence of hearing loss in the cisplatin-sodium thiosulfate group.
Otic drug preparations treatment chart for infections, pain, or wax build-up in the ear.
Acute otitis media treatment chart including select antibiotics and recommended doses.
Among 96 patients with 2 audiograms performed from which the rate of hearing loss could be calculated, 32 and 64 had CVD or related risk factors and were healthy controls, respectively.
Overall, 14.2% of all children had audiometric notches and high-frequency hearing loss; 4.5, 7.6, and 2.1% fulfilled the criteria of a notch, high-frequency hearing loss, and both, respectively.
The multivariable-adjusted relative risks (MVRRs) of hearing loss were 0.70 and 0.71 for women with scores in the highest vs the lowest quintile for Alternate Mediterranean diet (AMED) and Dietary Approaches to Stop Hypertension (DASH), respectively.
The rate of emergency department visitation was similar for all groups, except the marijuana plus tobacco group, which had a significantly higher rate of emergency department visits compared with controls.
Patients were treated for a median of 2.2 years. The researchers found that the primary cause of death was heart failure (79.4%), when identified. One death (3.7%) occurred among the 27 patients in the first trial group; among the 27 patients in the matched untreated group, there were 9 deaths (33.3%).
Compared to normal-hearing adults, those with a little trouble hearing, moderate trouble hearing, and a lot of trouble hearing had increased odds of accidental injury (odds ratios, 1.6, 1.7, and 1.9, respectively).
The Clinical Oncology Group Protocol ACCL0431 trial enrolled 125 pediatric patients newly diagnosed with a germ cell tumor, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma, or other malignancy.
The researchers found that the prevalence of hearing loss was 21.6% overall, 12.4% for conductive hearing loss, 6.9% for sensorineural hearing loss, and 2.3% for indeterminate hearing loss.
Otiprio is a sterile, preservative-free, otic suspension that is administered as a single-dose to the external ear canal of each affected ear by a healthcare professional.
The researchers found that the groups with and without metabolic syndrome had similar mean pure-tone audiometry thresholds at baseline but that recovery rates after treatment were significantly lower in the metabolic syndrome group.
The researchers detailed neuroanatomical networks that were affected or unaffected by auditory deprivation based on the comparison of CI candidates and control children.
Guidelines for the diagnosis and management of acute otitis media in pediatric patients.
The researchers found that 13 of 90 comparisons of prevalence showed a statistically significant increase across combinations of degree, frequency, and laterality of hearing loss.
"Newborn screening at birth is crucial to quickly identify infants at risk of hearing loss and congenital heart disease so they can receive early intervention and follow-up care," Brenda Fitzgerald, MD, director of the CDC.
Analysis of the cases found that standard doses of both oral and intravenous macrolide administration were associated with SNHL.
The researchers found that in cross-sectional analyses, participants with self-reported or objective moderate and poor hearing were more likely to have a dementia diagnosis than those with normal hearing, after adjustment for potential confounders.
The researchers measured the average accuracy — the percentage of the time that the participants understood the sentences. It was 76.5% without a hearing aid, 88.4% with the hearing aid, and 81.4 to 87.4% with four of the amplification devices.